<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T04:25:08Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/19452" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/19452</identifier><datestamp>2026-09-24T18:19:21Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Moran, Gerald</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Wilson, Kyle</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Medical Physics</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2016-06-06T17:06:36Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2016-06-06T17:06:36Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2010-12</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/19452</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/16448</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;P> Breast cancer has affected many women around the world throughout history. In order&#xd;
to recognize and treat the early signs of breast cancer, obtaining high quality images is crucial. A&#xd;
variety of imaging modalities are available for use in breast imaging, including conventional&#xd;
mammography and newer optical imaging techniques. One such optical imaging system is the&#xd;
ComfortScan™, which uses red light to image the breast and was the focus of this study. The&#xd;
objectives include investigating whether performing a large scale clinical trial with the&#xd;
ComfortScan TM would be warranted to further patient care and diagnostics for breast imaging,&#xd;
and determining whether the ComfortScan ™ would achieve better correlation to biopsy than&#xd;
mammography alone. An additional goal was to investigate whether the ComfortScan TM system&#xd;
would be beneficial as a mainstream method for a radiologist to diagnose breast cancer risk. &lt;/p> &lt;p>  The preliminary study with 19 patients demonstrated that there was no difference in&#xd;
diagnostic information between the near-infrared (NIR) image and mammography (p>O.OS).&#xd;
Anecdotal evidence suggests cases where mammography disagreed with biopsy, whereas&#xd;
ComfortScan TM agreed, though these were not statistically significant. Based on these&#xd;
encouraging results, a large scale clinical trial was launched to investigate the potential of&#xd;
widespread use of the ComfortScan ™. The large scale trial included 126 NIR images and&#xd;
found difference in diagnostic information between NIR and mammography (p&lt;O.OS).&#xd;
Mammography agreed with biopsy in 18/33 and the ComfortScan™ system agreed with&#xd;
biopsy in 25/33 cases. The sensitivity and specificity for the ComfortScan™ system was 83%&#xd;
and 67%, respectively. The sensitivity and specificity of mammography was 94% and 13%,&#xd;
respectively. This study included a variety of women with varying ages and BIRADS scores,&#xd;
and demonstrated the effective clinical use of a portable, non-ionizing, inexpensive imaging modality, indicating that the ComfortScan ™ system could likely be successful as a mainstream&#xd;
adjunct to mammography. &lt;/p> &lt;p> The potential of using polyvinyl alcohol cryogel (PVA-C) as a breast tissue mimic was&#xd;
investigated and PV A -C was then used to validate the mode of action of the ComfortScan TM&#xd;
system. Two experimental methods reported the absorption coefficients and reduced scattering&#xd;
coefficients of PV A-C. Using a double integrating sphere, the values were J.la = 0.012 ± 0.002&#xd;
mm-1 and J.ls' = 1.5 ± 0.2 mm-1 and using steady-state spatially resolved diffuse reflectance, the&#xd;
values were J.la = 0.017 ± 0.005 mm-1 and J.ls' = 1.3 ± 0.2 mm-1 at 640 nm. These values are&#xd;
comparable to typical absorption coefficients for tissue reported by others. &lt;/p> &lt;p> The mode of action suggested by DOBI (Dynamic Optical Breast Imaging) Medical&#xd;
for the ComfortScan ™ system is that under compression a malignant tumour will highly&#xd;
attenuate light, due to a partial collapse in the tumourous vasculature, resulting in an&#xd;
increased deoxygenation of blood over time. Using a PV A-C breast mimicking phantom, it&#xd;
was shown that by deoxygenating horse blood in a cavity, there was an increase in the&#xd;
attenuation of 640 nm light as compared with the surrounding phantom material; which&#xd;
suggests that the colour representative of malignancies on the ComfortScan ™ is caused by&#xd;
deoxygenating blood. Further evidence suggests that the ComfortS can TM system is not&#xd;
recognizing a total collapse of the vasculature and subsequent void of blood from the&#xd;
tumour as the trigger for malignant detection. The mode of action suggested by DOBI&#xd;
Medical is supported by our findings. &lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Dynamic</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Optical</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Imaging</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Breast Cancer</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">The Use of Dynamic Optical Imaging in Breast Cancer Detection</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>